Aberdeen Group’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.41M Sell
224,829
-192,915
-46% -$4.2M 0.01% 667
2026
Q1
$7.25M Buy
417,744
+72,436
+21% +$1.37M 0.01% 642
2025
Q4
$6.51M Buy
+345,308
New +$5.78M 0.01% 673

Other funds holding CDNA

Aberdeen Group's CDNA Position: Q2 2026 in Review

Aberdeen Group reduced its CareDx (CDNA) stake by 46% in Q2 2026, selling an estimated $4.2M and leaving 224,829 shares worth $6.41M. The position accounts for 0.01% of the portfolio, ranked #667.

Aberdeen Group first reported a position in CDNA in Q4 2025 and has held it in 3 quarters since. The position peaked at $7.25M in Q1 2026. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Aberdeen Group held 224,829 shares of CareDx worth $6.41M as of Q2 2026.
  • Aberdeen Group sold 192,915 CareDx shares in Q2 2026, an estimated $4.2M.
  • CareDx made up 0.01% of Aberdeen Group's portfolio in Q2 2026, its #667 holding.
  • Aberdeen Group first reported a position in CareDx in Q4 2025 and has held it in 3 quarters since.
  • Aberdeen Group's CareDx position peaked at $7.25M in Q1 2026.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.